Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear pore complex-interacting protein family member B8 (NPIPB8) is a protein encoded by the NPIPB8 gene in humans, annotated as a probable member of a gene family related to the nuclear pore complex (NPC)[2]. The nuclear pore complex is a large protein complex embedded in the nuclear envelope, responsible for the regulated exchange of macromolecules between the nucleus and cytoplasm[1][3][5]. NPIPB8 appears in data mining results for expression across tissues, but no experimental characterization has confirmed its direct interaction with the NPC or a specific biological function. It is classified as a protein-coding gene of unknown or poorly characterized function, and is not recognized as a drug target, receptor, enzyme, or transporter[2]. There are no known drugs, disease roles, or safety concerns linked to NPIPB8. This gene may serve as a candidate for future studies into uncharacterized proteins associated with the nuclear envelope, though currently its role remains speculative.
Not defined (no known drugs or established mechanisms)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear pore complex-interacting protein family member B8 (NPIPB8).